Agilent Is Down 29% Over 1,700 Days. What History Suggests

Agilent is Down 29% Over 1,700 Days. What History Suggests

A total of 1,721 days have passed since Agilent Technologies, Inc. (A) last traded at its all-time high, marking a prolonged 28.6% drawdown that has officially crossed into the red zone as of June 17, 2026. This extended decline has pushed the proprietary Drawdown Severity Score™ for the stock to 5.5, indicating a strong risk environment that surpasses the historical averages of the asset. Investors tracking the asset's historical drawdowns will find that this transition from the yellow zone to the red zone reflects a deep structural correction rather than a typical short-term pullback.

Understanding Agilent's Transition to a 5.5 Drawdown Severity Score™

As of June 17, 2026, the Drawdown Severity Score™ for Agilent stands at 5.5, which represents a transition from the yellow zone into the red zone. This proprietary score measures the intensity, speed, and duration of an asset's decline relative to its own historical baseline. A score of 5.5 falls into the "Strong" category, indicating that the selling pressure and duration of this correction have reached levels that historically precede prolonged recovery periods.

Our data shows that Agilent has experienced 43 total historical drawdown events since its inception. Across all of these past events, the average max drawdown was only -5.6%, and the average drawdown duration was 183 days. The 1,721-day drawdown and -28.6% depth represent extreme deviations from these historical averages, highlighting why the stock has entered the red zone.

The mathematical significance of a 5.5 severity score lies in how it weighs the duration of the drop alongside its depth. A shallow drop that lasts for years can have a similar severity profile to a sharp, sudden crash because both represent a prolonged period of capital destruction for investors who bought near the peak. In Agilent's case, the combination of a -28.6% drop and a 1,721-day duration creates a highly unusual risk profile. This indicates that the stock has struggled to find a sustainable bid for nearly five years, contrasting sharply with its historical tendency to resolve pullbacks within 183 days.

How This 29% Drop Compares to Agilent's History

To understand where Agilent stands, we must look at how past deep corrections behaved. Our data shows that Agilent has dropped by 20% or more only 2 times in its history. This small sample size is a critical caveat when evaluating historical averages, but the data remains highly instructive for understanding the scale of the decline.

On average, these comparable drops of 20% or more have required an average duration of 3,747 days to fully recover. This stands in stark contrast to the average duration of 183 days across all 43 of Agilent's historical drawdown events. The 1,721-day drawdown indicates that the stock is roughly halfway through the average recovery timeline seen in past major corrections, assuming historical patterns repeat.

When analyzing the 2 historical events where Agilent dropped by 20% or more, the average duration of 3,747 days highlights the extreme persistence of deep corrections for this specific asset. This average duration translates to over ten years of trading below previous highs before a full recovery was achieved. While the small sample size of 2 events means this average should be interpreted with caution, it serves as a reminder that Agilent has historically taken a very long time to repair major structural technical damage. This historical tendency toward prolonged recovery periods is a critical risk factor that distinguishes Agilent from faster-recovering peers in the healthcare and technology sectors.

Analyzing these historical metrics reveals that Agilent's correction is an outlier. The typical drawdown for the stock is brief and shallow, meaning the asset usually recovers quickly from market downturns. The 1,721-day period of trading below its peak represents a fundamental departure from the stock's standard behavior over its trading history.

Valuation Multiples vs. Historical Drawdown Percentiles

Our data as of the valuation snapshot date of 2026-06-16 shows that Agilent's Price-to-Sales (P/S) ratio stands at 5.1, placing it in the 73rd percentile of its own daily P/S record since 2006-06-15, which is above its historical median of 3.6. Meanwhile, the EV-to-EBITDA ratio stands at 19.7, placing it in the 60th percentile of its own daily EV-to-EBITDA record since 2006-06-15, which is within its own typical range and slightly above its historical median of 18.5. This shows that despite the -28.6% drawdown from its peak, Agilent's valuation multiples remain in the upper half of their historical distributions, indicating that the stock's price decline has not resulted in historically depressed valuation multiples relative to its own past.

External Catalysts and Market Developments Driving Agilent

To understand the fundamental drivers behind this 1,721-day drawdown, we look to recent market events and reporting. According to Yahoo Finance, Agilent declined in the first quarter of the year amid speculation surrounding a potential QIAGEN acquisition, which introduced uncertainty regarding the company's capital allocation strategy. Additionally, reports from MarketWatch highlighted that Agilent stock underperformed when compared to competitors on key trading days, reflecting broader relative weakness in the life sciences and diagnostics sector.

However, some positive momentum has emerged to counter this long-term slide. According to Investor's Business Daily, Agilent recently retook its 200-day moving average, driven by bullish market sentiment. Furthermore, Barron's reported that Agilent experienced its best trading day since 2002 following an earnings report that left Wall Street analysts with very few points of criticism, suggesting that fundamental performance may be starting to stabilize even as the long-term drawdown remains unresolved.

These contrasting news flows highlight the tension between short-term earnings beats and long-term structural headwinds. While positive earnings surprises can cause sharp, single-day rallies, they have not yet been sufficient to reverse the broader -28.6% drawdown. The market continues to weigh the company's long-term growth prospects against sector-wide headwinds and capital deployment decisions.

Assessing the Risk Profile of a 1,721-Day Correction

A drawdown lasting 1,721 days represents an unusual environment for any large-cap stock. Standard market corrections typically resolve within a year, but Agilent's extended duration highlights a persistent shift in investor expectations. Our data shows that the drawdown depth of -28.6% is more than five times deeper than the average historical drawdown of -5.6% for this stock.

Holding an asset during a 1,721-day drawdown introduces significant opportunity cost for investors. During this nearly five-year period, the broader equity markets have experienced multiple cycles of expansion, while Agilent capital has remained locked in a negative return profile relative to its peak. The -28.6% drawdown means that an investor who bought at the all-time high of $174.07 requires a 40% gain from the current price of $124.33 just to break even. This mathematical reality underscores the importance of monitoring drawdown severity metrics to identify when an asset's risk profile has fundamentally shifted.

This slow recovery trend is crucial for risk management. While some assets bounce back rapidly from deep corrections, Agilent's historical data suggests a tendency toward prolonged consolidation periods. Understanding this characteristic helps investors set realistic expectations regarding the timeline required for the stock to challenge its previous all-time high of $174.07 again.

Key Thresholds to Monitor for Agilent's Recovery

To gauge whether Agilent is beginning to stabilize or if further downside is likely, investors can monitor specific quantitative thresholds. A shift back into the yellow zone would require a sustained reduction in the Drawdown Severity Score™ below the 5.0 level. Key technical markers, such as maintaining the 200-day moving average highlighted by Investor's Business Daily, will also serve as critical indicators of whether the stock can break its long-term downward trend.

Conversely, if the drawdown deepens beyond the -28.6% level, the severity score could climb further into the red zone. Investors tracking the stock should closely monitor these metrics to determine if the asset is beginning to form a long-term bottom or if the 1,721-day decline will continue to extend. Our platform will continue to track these metrics daily to provide updated risk assessments as the price action develops.